Journals / Balkan Medical Journal / 2012 / Cilt: 29 - Sayı: 4

Yoğun bakım ünitesinde ventilatör ilişkili pnömoniyi önlemede Glutamin destekli total parenteral beslenme

Glutamine supplemented parenteral nutrition to prevent ventilator- Associated pneumonia in the intensive care unit

Pages
414–418
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Glutamine-supplemented TPN may have no superiority over unsupplemented enteral and TPN in preventing VAP.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Ventilator-associated pneumonia (VAP) is a form of nosocomial pneumonia that increases patient morbidity and mortality, length of hospital stay, and healthcare costs.
📊
Key Findings & Data:Glutamine preserves the intestinal mucosal structure, increases immune function, and reduces harmful changes in gut permeability in patients receiving total parenteral nutrition (TPN).
💡
Conclusion & Impact:Glutamine-supplemented TPN may have no superiority over unsupplemented enteral and TPN in preventing VAP.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Ventilator-associated pneumonia (VAP) is a form of nosocomial pneumonia that increases patient morbidity and mortality, length of hospital stay, and healthcare costs. Glutamine preserves the intestinal mucosal structure, increases immune function, and reduces harmful changes in gut permeability in patients receiving total parenteral nutrition (TPN). We hypothesized that TPN supplemented by glutamine might prevent the development of VAP in patients on mechanical ventilator support in the intensive care unit (ICU). Material and Methods: With the approval of the ethics committee and informed consent from relatives, 60 patients who were followed in the ICU with mechanical ventilator support were included in our study. Patients were divided into three groups. The first group received enteral nutrition (n=20), and the second was prescribed TPN (n=20) while the third group was given glutamine-supplemented TPN (n=20). C-reactive protein (CRP), sedimentation rate, body temperature, development of purulent secretions, increase in the amount of secretions, changes in the characteristics of secretions and an increase in requirement of deep tracheal aspiration were monitored for seven days by daily examination and radiographs. Results: No statistically significant difference was found among groups in terms of development of VAP (p=0.622). Conclusion: Although VAP developed at a lower rate in the glutamine-supplemented TPN group, no statistically significant difference was found among any of the groups. Glutamine-supplemented TPN may have no superiority over unsupplemented enteral and TPN in preventing VAP.

Özet

Amaç: Ventilatör ilişkili pnömoni (VAP), mortalite ve morbiditeyi artıran, hastanede kalış süresini uzatan ve hastane giderlerini artıran bir nazokomial pnömoni formudur. Glutamin intestinal mukozal yapıyı korur, immün fonksiyonları artırır ve total parenteral beslenme (TPN) uygulanan hastalarda zararlı değişiklikleri azaltır. Biz yoğun bakım ünitesinde (YBÜ) mekanik ventilatör desteği alan hastalarda VAP gelişiminin glutamin destekli TPN ile önlenebileceği hipotezini kurduk. Materyal ve Metodlar: Çalışmamızda etik kurul onayı ve bilgilendirilmiş onam alındıktan sonra YBÜ’nde mekanik ventilatör desteği alan 60 hasta takip edildi. Hastalar 3 gruba ayrıldı. İlk grup enteral beslenme (n=20) alırken, ikinci gruba TPN (n=20), üçüncü gruba ise glutamin destekli TPN (n=20) başlandı. C-reaktif protein (CRP), sedimentasyon hızı, vücut ısısı, pürülan sekresyon gelişip gelişmediği, sekresyon miktarında artış olup olmadığı, sekresyonların karakterinde değişiklik ve derin trakeal aspirasyon ihtiyacında artış olup olmadığı günlük muayeneler ve radyografi ile takip edildi. Bulgular: Gruplar arasında VAP gelişim açısından istatistiksel olarak anlamlı fark bulunmadı (p=0.622). Sonuç: Glutamin destekli TPN alan grupta daha az oranda VAP gelişmesine rağmen, gruplar arasındaki fark istatistiksel olarak anlamlı değildi. Glutamin destekli TPN, VAP gelişimini önlemede glutaminsiz TPN ve enteral beslenmeden üstün değildir.

🔖

Cite This Article

TOMAK, Y., TÜRKAY, M. A., HÜSEYİNOĞLU, Ü., KATI, İ., TEKİN, M. (2022). Yoğun bakım ünitesinde ventilatör ilişkili pnömoniyi önlemede Glutamin destekli total parenteral beslenme. Balkan Medical Journal, Cilt: 29 - Sayı: 4, 414–418. https://ajindex.com/articles/461699

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bonten MJ. Controversies on diagnosis and prevention of ventilator-associated pneumonia. Diagn Microbiol Infect Dis 1999
  2. [CrossRef] 2. Rello J, Paiva JA, Baraibar J, Barcenilla F, Bodi M, Castander D, et al. International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia. Chest 2001
  3. [CrossRef] 3. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005
  4. [CrossRef] 4. Robert PR, Zolaga GP. Enteral Nutrition, In: Textbook of Critical Care Ed. W.C. Schomaker, 4 th Ed., W.B. Saunders
  5. pp.875-97. 5. Furst P, Albers S, Stehle P. Glutamine-containing dipeptides in parenteral nutrition. JPEN 1990
  6. [CrossRef] 6. Wischmeyer PE, Lynch J, Liedel J, Wolfson R, Riehm J, Gottlieb L, et al. Glutamine administration reduces gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 2000
  7. [CrossRef] 7. Jiang ZM, Jiang H. [The clinical efficacy of glutamine dipeptides on postoperative patients: an updated systematic review of randomized controlled trials from Europe and Asia (1997-2005)]. Zhonghua Yi Xue Zhi 2006
  8. Torres A, Aznar R, Gatell JM, Jiménez P, González J, Ferrer A, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990
  9. [CrossRef] 9. Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993
  10. [CrossRef] 10. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilatorassociated pneumonia. Chest 1993
  11. [CrossRef] 11. Joshi N, Localio AR, Hamory BH. A predictive risk index for nosocomial pneumonia in the intensive care unit. Am J Med 1992
  12. [CrossRef] 12. Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA 1993
  13. [CrossRef] 13. Antonelli M, Moro ML, Capelli O, De Blasi RA, D’Errico RR, Conti G, et al. Risk factors for early onset pneumonia in trauma patients. Chest 1994
  14. [CrossRef] 14. Cunnion KM, Weber DJ, Broadhead WE, Hanson LC, Piepe